Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Motor Function Test Reliability During the NeuroNEXT Spinal Muscular Atrophy Infant Biomarker Study.

Krosschell KJ, Bosch M, Nelson L, Duong T, Lowes LP, Alfano LN, Benjamin D, Carry TB, Devine G, Kelley C, Gadekan R, Malkus EC, Pasternak A, Provance-Orr S, Roemeiser-Logan L, Nicorici A, Trussell D, Young SD, Fetterman JR, Montes J, Powers PJ, Quinones R, Quigley J, Coffey CS, Yankey JW, Bartlett A, Kissel JT, Kolb SJ; NeuroNEXT Clinical Trial Network and on behalf of the NN101 SMA Biomarker Investigators.

J Neuromuscul Dis. 2018;5(4):509-521. doi: 10.3233/JND-180327.

PMID:
30223401
2.

Outcomes of Colorado children with acute flaccid myelitis at 1 year.

Martin JA, Messacar K, Yang ML, Maloney JA, Lindwall J, Carry T, Kenyon P, Sillau SH, Oleszek J, Tyler KL, Dominguez SR, Schreiner TL.

Neurology. 2017 Jul 11;89(2):129-137. doi: 10.1212/WNL.0000000000004081. Epub 2017 Jun 14.

3.

Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect.

Balaban B, Matthews DJ, Clayton GH, Carry T.

Am J Phys Med Rehabil. 2005 Nov;84(11):843-50.

PMID:
16244521
4.

Supplemental Content

Support Center